Maze Therapeutics Inc
Maze Therapeutics Inc (MAZE) Implied Volatility Current
MAZE implied volatility is 70%. IV Rank is 8%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking MAZE implied volatility helps you identify when options premiums on Maze Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Maze Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when MAZE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Maze Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For MAZE, tracking metrics like MAZE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on MAZE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs includes MZE829, an oral small molecule inhibitor of apolipoprotein L1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc.
and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where MAZE implied volatility sits today versus where it has been. Our scanner ranks Maze Therapeutics Inc implied volatility against its historical range, surfaces extremes in MAZE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Maze Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track MAZE IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→